Global Acyclovir New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

global acyclovir

global pharmaceuticals limited - aciclovir 800mg - tablet - 800 mg - active: aciclovir 800mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose povidone sodium starch glycolate

ADIZEM CD 120 Israel - Inggeris - Ministry of Health

adizem cd 120

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 120 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

ADIZEM CD 180 Israel - Inggeris - Ministry of Health

adizem cd 180

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 180 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

ADIZEM CD 240 Israel - Inggeris - Ministry of Health

adizem cd 240

rafa laboratories ltd - diltiazem hydrochloride - capsules controlled release - diltiazem hydrochloride 240 mg - benzothiazepine derivatives - calcium channel blocker that is indicated for the treatment of hypertension and angina.

SPORANOX 100MG HARD CAPSULES Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

sporanox 100mg hard capsules

imed healthcare ltd. - itraconazole - capsules hard - 100 milligram

XALKORI 200 MG Israel - Inggeris - Ministry of Health

xalkori 200 mg

pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.

XALKORI 200 MG Israel - Inggeris - Ministry of Health

xalkori 200 mg

pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.